DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients

This publication has 18 references indexed in Scilit:

• Screening for Lung Cancer
  Chest, 2018
• Validation of the SHOX2 / PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease
  Journal of Thoracic Oncology, 2017
• Transthoracic Needle Biopsies: It's More than Just Hitting the Bull's-eye
  Clinical Cancer Research, 2016
• Standard-dose vs. low-dose CT protocols in the evaluation of localized lung lesions: Capability for lesion characterization—iLEAD study
  European Journal of Radiology Open, 2016
• Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Guideline
  Journal of Clinical Oncology, 2014
• Assessment of SHOX2 methylation in EBUS-TBNA specimen improves accuracy in lung cancer staging
  Annals of Oncology, 2013
• Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
  New England Journal of Medicine, 2011
• Correlation of SHOX2 Gene Amplification and DNA Methylation in Lung Cancer Tumors
  BMC Cancer, 2011
• Eicosanoids and cancer
  Nature Reviews Cancer, 2010
• The fundamental role of epigenetic events in cancer
  Nature Reviews Genetics, 2002